Report China - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Sep 15, 2022

China - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

China: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in China

The Chinese prophylactic medicaments containing insulin market was estimated at $X in 2021, remaining stable against the previous year. Overall, consumption, however, recorded a prominent increase. Prophylactic medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2021, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in China

In value terms, prophylactic medicaments containing insulin production expanded to $X in 2021 estimated in export price. Over the period under review, production, however, continues to indicate resilient growth. The growth pace was the most rapid in 2013 when the production volume increased by X%. Over the period under review, production attained the peak level at $X in 2019; however, from 2020 to 2021, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from China

Prophylactic medicaments containing insulin exports from China soared to X tons in 2021, with an increase of X% on 2020. Overall, exports enjoyed a significant expansion. The growth pace was the most rapid in 2013 when exports increased by X% against the previous year. The exports peaked in 2021 and are expected to retain growth in years to come.

In value terms, prophylactic medicaments containing insulin exports skyrocketed to $X in 2021. Over the period under review, exports recorded significant growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

Denmark (X tons) was the main destination for prophylactic medicaments containing insulin exports from China, with a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Denmark exceeded the volume sent to the second major destination, France (X tons), twofold. Pakistan (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Denmark stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (+X% per year) and Pakistan (+X% per year).

In value terms, Denmark ($X) remains the key foreign market for prophylactic medicaments containing insulin exports from China, comprising X% of total exports. The second position in the ranking was held by France ($X), with a X% share of total exports. It was followed by Australia, with a X% share.

From 2012 to 2021, the average annual growth rate of value to Denmark totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (+X% per year) and Australia (-X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2021, jumping by X% against the previous year. Overall, export price indicated a strong increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major foreign markets. In 2021, the country with the highest price was Denmark ($X per ton), while the average price for exports to Brazil ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Italy (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into China

In 2021, purchases abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the fourth year in a row after two years of decline. In general, imports continue to indicate a strong increase. The pace of growth was the most pronounced in 2013 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2014 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports skyrocketed to $X in 2021. Overall, imports recorded a strong increase. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, imports attained the peak figure in 2021 and are likely to see gradual growth in the near future.

Imports by Country

In 2021, Denmark (X tons) constituted the largest prophylactic medicaments containing insulin supplier to China, with a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Denmark exceeded the figures recorded by the second-largest supplier, France (X tons), threefold. Italy (X tons) ranked third in terms of total imports with an X% share.

From 2012 to 2021, the average annual growth rate of volume from Denmark amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: France (+X% per year) and Italy (+X% per year).

In value terms, Denmark ($X), Germany ($X) and France ($X) were the largest prophylactic medicaments containing insulin suppliers to China, together accounting for X% of total imports. Italy lagged somewhat behind, accounting for a further X terms of the main suppliers, Italy, with a CAGR of +X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2021, growing by X% against the previous year. In general, import price indicated a noticeable increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, prophylactic medicaments containing insulin import price increased by +X% against 2018 indices. The most prominent rate of growth was recorded in 2019 when the average import price increased by X%. Over the period under review, average import prices hit record highs in 2021 and is likely to see steady growth in the near future.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Germany ($X per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Germany (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin consumption in 2021 were China, the United States and India, together accounting for 52% of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin production in 2021 were China, the United States and India, together accounting for 52% of global production.
What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses to China?
+
In value terms, the largest prophylactic medicaments containing insulin suppliers to China were Denmark, Germany and France, with a combined 90% share of total imports. These countries were followed by Italy, which accounted for a further 8.5%.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses from China?
+
In value terms, Denmark remains the key foreign market for prophylactic medicaments containing insulin exports from China, comprising 73% of total exports. The second position in the ranking was taken by France, with a 21% share of total exports. It was followed by Australia, with a 2.4% share.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in China?
+
In 2021, the average prophylactic medicaments containing insulin export price amounted to $592,225 per ton, growing by 49% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in China?
+
The average prophylactic medicaments containing insulin import price stood at $511,889 per ton in 2021, growing by 15% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in China
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2012–2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012–2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012–2021
Figure 5:
Trade Balance, In Physical Terms, 2012–2021
Figure 6:
Trade Balance, In Value Terms, 2012–2021
Figure 7:
Per Capita Consumption, 2012–2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET